dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversity of Minho
dc.contributorFaculdade INGÁ
dc.contributorUniversidade Federal de São Carlos (UFSCar)
dc.date.accessioned2014-05-27T11:28:46Z
dc.date.available2014-05-27T11:28:46Z
dc.date.created2014-05-27T11:28:46Z
dc.date.issued2013-04-01
dc.identifierJournal of Applied Microbiology, v. 114, n. 4, p. 1175-1183, 2013.
dc.identifier1364-5072
dc.identifier1365-2672
dc.identifierhttp://hdl.handle.net/11449/74977
dc.identifier10.1111/jam.12102
dc.identifierWOS:000316572200026
dc.identifier2-s2.0-84875537766
dc.identifier7601364286525384
dc.description.abstractAim: The aim of this study was to assess the effect of different silver nanoparticles (SN) concentrations on the matrix composition and structure of Candida albicans and Candida glabrata biofilms. Methods and Results: Candida biofilms were developed in 6-well microtiter plates during 48 h. After, these biofilms were exposed to 13·5 or 54 μg SN ml-1 for 24 h. Then, extracellular matrices were extracted from biofilms and analysed chemically in terms of proteins, carbohydrates and DNA. To investigate the biofilm structure, scanning electron microscopy (SEM) and epifluorescence microscopy were used. SN interfered with the matrix composition of Candida biofilms tested in terms of protein, carbohydrate and DNA, except for the protein content of C. albicans biofilm. By SEM, Candida biofilms treated with SN revealed structural differences, when compared with the control groups. Further, SN showed a trend of agglomeration within the biofilms. Epifluorescence microscopy images suggest that SN induced damage on cell walls of the Candida isolates tested. Conclusions: In general, irrespective of concentration, SN affected the matrix composition and structure of Candida biofilms and these findings may be related to the mechanisms of biocide action of SN. Significance and Impact of the Study: This study reveals new insights about the behaviour of SN when in contact with Candida biofilms. SN may contribute to the development of therapies to prevent or control Candida infections. © 2012 The Society for Applied Microbiology.
dc.languageeng
dc.relationJournal of Applied Microbiology
dc.relation2.160
dc.relation0,795
dc.relation0,795
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectBiofilms
dc.subjectCandida albicans
dc.subjectCandida glabrata
dc.subjectFungal infections
dc.subjectSilver nanoparticles
dc.subjectcarbohydrate
dc.subjectDNA
dc.subjectprotein
dc.subjectsilver nanoparticle
dc.subjectbiofilm
dc.subjectcolloid
dc.subjectconcentration (composition)
dc.subjectfluorescence spectroscopy
dc.subjectfungus
dc.subjectinfectivity
dc.subjectnanotechnology
dc.subjectscanning electron microscopy
dc.subjectsilver
dc.subjectcontrolled study
dc.subjectepifluorescence microscopy
dc.subjectfungal cell wall
dc.subjectfungal structures
dc.subjectfungus isolation
dc.subjectmicrotiter plate assay
dc.subjectnonhuman
dc.subjectCandida
dc.titleSilver colloidal nanoparticles: Effect on matrix composition and structure of Candida albicans and Candida glabrata biofilms
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución